FDA+ channel feed – Endpoints News

FDA+ channel feed

Inside the FDA’s ‘listening’ tour: Officials agree US lags behind China on drug development

3 weeks ago

FDA's top cell and gene therapy leaders exit agency in ongoing CBER changes

3 weeks ago

Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot

3 weeks ago

CBER head Prasad adds chief medical and scientific officer to his title

3 weeks ago

FDA approves CSL’s prophylactic for severe swelling condition

4 weeks ago

FDA unveils one-year pilot to speed some new drugs to market in just one month

4 weeks ago

What's coming in five years? FDA chief points to universal flu vaccine, new approval pathway

4 weeks ago

KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’

4 weeks ago

FDA's oncology adcomm to review GSK's Blenrep relaunch plans

4 weeks ago

Another round of consolidation is coming, FDA commissioner tells staff

4 weeks ago

Moderna wins expanded label for RSV shot, allowing use in at-risk, younger adults

4 weeks ago

Kennedy's vaccine doubts hinge on 'inert' placebos, but experts say he misunderstands the science

4 weeks ago

In surprise, FDA approves UroGen's chemo-turned-gel drug after negative adcomm vote

4 weeks ago

Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases

4 weeks ago

RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone

4 weeks ago

House appropriators call for FDA tweaks on accelerated approvals, biosimilars

4 weeks ago

Nuvation Bio scores first FDA approval for new lung cancer drug

4 weeks ago

FDA’s Makary says he wasn’t part of decision to gut ACIP, defers possible VRBPAC changes to Prasad

5 weeks ago

FDA places hold on Gilead's studies of HIV treatment pill combo

5 weeks ago

Updated: HHS chief Kennedy removes all ACIP members, dismantling vaccine board

5 weeks ago

FDA reinstates generic drug policy group let go in April firings

5 weeks ago

Former HHS lawyer on Novavax delay: Mixing politics and approvals 'imperils' public health

5 weeks ago

FDA adds biomarker limits to stomach, esophageal cancer labels for Merck's Keytruda and BMS' Opdivo

5 weeks ago

Updated: Merck wins FDA approval for RSV antibody drug, making a hot market more competitive

5 weeks ago

First page Previous page 123 4 5 Next page Last page